Stručni rad
The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm
Duška Glavaš
; Klinički bolnički centar Split, Split, Hrvatska
Puni tekst: hrvatski pdf 48 Kb
str. 24-26
preuzimanja: 291
citiraj
APA 6th Edition
Glavaš, D. (2012). The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica, 7 (1-2), 24-26. Preuzeto s https://hrcak.srce.hr/77047
MLA 8th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica, vol. 7, br. 1-2, 2012, str. 24-26. https://hrcak.srce.hr/77047. Citirano 22.12.2024.
Chicago 17th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica 7, br. 1-2 (2012): 24-26. https://hrcak.srce.hr/77047
Harvard
Glavaš, D. (2012). 'The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm', Cardiologia Croatica, 7(1-2), str. 24-26. Preuzeto s: https://hrcak.srce.hr/77047 (Datum pristupa: 22.12.2024.)
Vancouver
Glavaš D. The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica [Internet]. 2012 [pristupljeno 22.12.2024.];7(1-2):24-26. Dostupno na: https://hrcak.srce.hr/77047
IEEE
D. Glavaš, "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm", Cardiologia Croatica, vol.7, br. 1-2, str. 24-26, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/77047. [Citirano: 22.12.2024.]
Puni tekst: engleski pdf 48 Kb
str. 24-26
preuzimanja: 290
citiraj
APA 6th Edition
Glavaš, D. (2012). The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica, 7 (1-2), 24-26. Preuzeto s https://hrcak.srce.hr/77047
MLA 8th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica, vol. 7, br. 1-2, 2012, str. 24-26. https://hrcak.srce.hr/77047. Citirano 22.12.2024.
Chicago 17th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica 7, br. 1-2 (2012): 24-26. https://hrcak.srce.hr/77047
Harvard
Glavaš, D. (2012). 'The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm', Cardiologia Croatica, 7(1-2), str. 24-26. Preuzeto s: https://hrcak.srce.hr/77047 (Datum pristupa: 22.12.2024.)
Vancouver
Glavaš D. The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica [Internet]. 2012 [pristupljeno 22.12.2024.];7(1-2):24-26. Dostupno na: https://hrcak.srce.hr/77047
IEEE
D. Glavaš, "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm", Cardiologia Croatica, vol.7, br. 1-2, str. 24-26, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/77047. [Citirano: 22.12.2024.]
Sažetak
In the treatment of chronic heart failure (HF) as the major problem of modern medicine, there is a need to develop new therapeutic approaches, so each new medicamentous intervention undertaken in respect to adverse pathophysiological course of this disease is worth cardiologist’s attention. The trial SHIFT (Systolic Heart failure treatment with the IF inhibitor ivabradine Trial) which investigated the effect of adding ivabradine to patients with HF who were previously treated according to the guidelines, has been published. SHIFT has confirmed that further slowdown of the heart rate by ivabradine may increase the benefits of neurohormonal blockade in chronic HF. Some international societies of cardiology reacted to the results of this trial by adapting the existing national guidelines or publicizing the consensus, which firmly define the place ivabradine in treating patients with HF.
Ključne riječi
heart failure; heart rate; , ivabradine
Hrčak ID:
77047
URI
https://hrcak.srce.hr/77047
Datum izdavanja:
26.1.2012.
Podaci na drugim jezicima:
hrvatski
Posjeta: 1.463
*
